4481

    524348

    AARTIDRUGS

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    AARTI DRUGS LTD. Share Price Today

    AARTI DRUGS LTD. is currently trading at ₹422.3, up by ₹2.39 from the previous close. The stock touched an intraday high of ₹426.45 and a low of ₹410.20 during the latest trading session. Over the past one year, AARTI DRUGS LTD. has delivered a loss of 18.44%, while the stock has gained 14.84% in the last one month.

    AARTI DRUGS LTD. performance

    Today’s low Today’s high
    ₹ 410.20 ₹ 426.45
    ₹ 422.30
    52 week low 52 week high
    ₹ 318.95 ₹ 564.05
    ₹ 422.30
    Open Price ₹ 422.00
    Prev. Close ₹ 419.90
    Volume (Shares) 221704.00
    Total traded value ₹ 936.25
    Upper Circuit ₹ 503.85
    Lower Circuit ₹ 335.95
    info

    Investment Returns

    Over 1 Month 14.84% Over 3 Months 13.15% Over 6 Months 12.16% Over 1 Year -18.44%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    AARTI DRUGS LTD. fundamentals


    • Market cap (Cr) 3,854.30
    • P/E Ratio (TTM) 22.81
    • Beta 0.91
    • Book Value / share 153.91
    • Return on equity 12.97%
    • EPS (TTM) 18.54
    • Dividend yield 0.47%
    • Net profit/quarter (Cr) 44.96
    info icon alternate text
    • Market cap (Cr) 3,860.30
    • P/E Ratio (TTM) 22.81
    • Beta 0.86
    • Book Value / share 153.91
    • Return on equity 12.97%
    • EPS (TTM) 18.54
    • Dividend yield 0.47%
    • Net profit/quarter (Cr) 44.96
    info icon alternate text

    AARTI DRUGS LTD. Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 631.68
    Operating Expense 573.94
    Net Profit 44.96
    Net Profit Margin (%) 7.11
    Earnings Per Share (EPS) 4.93
    EBITDA 80.11
    Effective Tax Rate (%) 23.23
    Particulars DEC 2025 (Values in Cr)
    Revenue 528.80
    Operating Expense 508.31
    Net Profit 33.84
    Net Profit Margin (%) 6.39
    Earnings Per Share (EPS) 3.71
    EBITDA 43.53
    Effective Tax Rate (%) -55.87
    Particulars SEP 2025 (Values in Cr)
    Revenue 578.95
    Operating Expense 523.31
    Net Profit 41.78
    Net Profit Margin (%) 7.21
    Earnings Per Share (EPS) 4.58
    EBITDA 75.34
    Effective Tax Rate (%) 25.09
    Particulars JUN 2025 (Values in Cr)
    Revenue 520.96
    Operating Expense 476.09
    Net Profit 48.64
    Net Profit Margin (%) 9.33
    Earnings Per Share (EPS) 5.33
    EBITDA 64.34
    Effective Tax Rate (%) -7.49
    Particulars MAR 2025 (Values in Cr)
    Revenue 622.96
    Operating Expense 554.00
    Net Profit 61.48
    Net Profit Margin (%) 9.86
    Earnings Per Share (EPS) 6.74
    EBITDA 90.36
    Effective Tax Rate (%) 13.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 2260.39
    Operating Expense 2081.67
    Net Profit 169.22
    Net Profit Margin (%) 7.48
    Earnings Per Share (EPS) 18.54
    EBITDA 263.33
    Effective Tax Rate (%) 6.66
    Particulars MAR 2025 (Values in Cr)
    Revenue 2173.65
    Operating Expense 1988.47
    Net Profit 157.31
    Net Profit Margin (%) 7.23
    Earnings Per Share (EPS) 17.18
    EBITDA 276.22
    Effective Tax Rate (%) 20.85
    Particulars MAR 2024 (Values in Cr)
    Revenue 2266.91
    Operating Expense 2078.60
    Net Profit 141.88
    Net Profit Margin (%) 6.25
    Earnings Per Share (EPS) 15.35
    EBITDA 270.31
    Effective Tax Rate (%) 26.28
    Particulars MAR 2023 (Values in Cr)
    Revenue 2497.97
    Operating Expense 2295.39
    Net Profit 152.81
    Net Profit Margin (%) 6.11
    Earnings Per Share (EPS) 16.50
    EBITDA 284.63
    Effective Tax Rate (%) 25.38
    Particulars MAR 2022 (Values in Cr)
    Revenue 2251.17
    Operating Expense 2000.44
    Net Profit 195.00
    Net Profit Margin (%) 8.66
    Earnings Per Share (EPS) 21.04
    EBITDA 322.95
    Effective Tax Rate (%) 23.67
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 149.99
    ROE % 12.68
    ROCE % 13.07
    Total Debt to Total Equity 0.44
    EBITDA Margin 12.84
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 139.40
    ROE % 13.87
    ROCE % 14.97
    Total Debt to Total Equity 0.47
    EBITDA Margin 12.85
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 128.77
    ROE % 14.93
    ROCE % 15.36
    Total Debt to Total Equity 0.52
    EBITDA Margin 11.47
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 111.92
    ROE % 21.03
    ROCE % 20.33
    Total Debt to Total Equity 0.46
    EBITDA Margin 13.82
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 98.01
    ROE % 35.81
    ROCE % 33.38
    Total Debt to Total Equity 0.47
    EBITDA Margin 20.66
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 137.10
    ROE % 12.97
    ROCE % 13.49
    Total Debt to Total Equity 0.41
    EBITDA Margin 12.82
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 127.83
    ROE % 12.39
    ROCE % 13.65
    Total Debt to Total Equity 0.44
    EBITDA Margin 12.06
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 120.34
    ROE % 14.65
    ROCE % 15.24
    Total Debt to Total Equity 0.51
    EBITDA Margin 11.54
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 104.99
    ROE % 21.29
    ROCE % 20.38
    Total Debt to Total Equity 0.47
    EBITDA Margin 14.48
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 92.23
    ROE % 34.79
    ROCE % 32.19
    Total Debt to Total Equity 0.48
    EBITDA Margin 21.46
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 7.56
    Total Assets 2574.67
    Total Liabilities 2574.67
    Total Equity 1369.34
    Share Outstanding 9
    Price to Book Ratio 2.48
    Return on Assets (%) 6.53
    Return on Capital (%) 8.49
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 9.43
    Total Assets 2432.35
    Total Liabilities 2432.35
    Total Equity 1281.95
    Share Outstanding 9
    Price to Book Ratio 3.39
    Return on Assets (%) 7.04
    Return on Capital (%) 9.29
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 8.95
    Total Assets 2421.39
    Total Liabilities 2421.39
    Total Equity 1192.66
    Share Outstanding 9
    Price to Book Ratio 2.81
    Return on Assets (%) 6.86
    Return on Capital (%) 9.24
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 22.33
    Total Assets 2207.95
    Total Liabilities 2207.95
    Total Equity 1036.30
    Share Outstanding 9
    Price to Book Ratio 4.09
    Return on Assets (%) 9.28
    Return on Capital (%) 13.02
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 9.77
    Total Assets 1766.01
    Total Liabilities 1766.01
    Total Equity 913.40
    Share Outstanding 9
    Price to Book Ratio 7.53
    Return on Assets (%) 15.87
    Return on Capital (%) 22.29
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 4.57
    Total Assets 2272.79
    Total Liabilities 2272.79
    Total Equity 1251.35
    Share Outstanding 9
    Price to Book Ratio 2.48
    Return on Assets (%) 6.92
    Return on Capital (%) 8.91
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 3.82
    Total Assets 2171.61
    Total Liabilities 2171.61
    Total Equity 1175.20
    Share Outstanding 9
    Price to Book Ratio 3.39
    Return on Assets (%) 6.53
    Return on Capital (%) 8.61
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 2.67
    Total Assets 2195.49
    Total Liabilities 2195.49
    Total Equity 1114.30
    Share Outstanding 9
    Price to Book Ratio 2.81
    Return on Assets (%) 6.96
    Return on Capital (%) 9.28
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.20
    Total Assets 2034.52
    Total Liabilities 2034.52
    Total Equity 972.17
    Share Outstanding 9
    Price to Book Ratio 4.09
    Return on Assets (%) 9.58
    Return on Capital (%) 13.11
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 3.80
    Total Assets 1637.00
    Total Liabilities 1637.00
    Total Equity 859.61
    Share Outstanding 9
    Price to Book Ratio 7.53
    Return on Assets (%) 15.74
    Return on Capital (%) 21.68
    Particulars MAR 2025 (Values in Cr)
    Net Income 211.77
    Cash from Operations 299.70
    Cash from Investing -164.63
    Cash from Financing -82.11
    Net change in Cash -2.16
    Free Cash Flow 476.86
    Particulars MAR 2024 (Values in Cr)
    Net Income 235.52
    Cash from Operations 421.32
    Cash from Investing -223.65
    Cash from Financing -136.03
    Net change in Cash -0.76
    Free Cash Flow 647.65
    Particulars MAR 2023 (Values in Cr)
    Net Income 224.18
    Cash from Operations 192.99
    Cash from Investing -163.97
    Cash from Financing 16.54
    Net change in Cash -14.10
    Free Cash Flow 357.81
    Particulars MAR 2022 (Values in Cr)
    Net Income 269.95
    Cash from Operations 153.79
    Cash from Investing -149.63
    Cash from Financing 92.02
    Net change in Cash 12.79
    Free Cash Flow 305.76
    Particulars MAR 2021 (Values in Cr)
    Net Income 369.01
    Cash from Operations 251.62
    Cash from Investing -71.77
    Cash from Financing -81.12
    Net change in Cash 2.04
    Free Cash Flow 339.85
    Particulars MAR 2025 (Values in Cr)
    Net Income 198.75
    Cash from Operations 272.02
    Cash from Investing -134.91
    Cash from Financing -84.59
    Net change in Cash 0.56
    Free Cash Flow 409.31
    Particulars MAR 2024 (Values in Cr)
    Net Income 192.48
    Cash from Operations 388.33
    Cash from Investing -187.09
    Cash from Financing -148.80
    Net change in Cash 1.20
    Free Cash Flow 577.65
    Particulars MAR 2023 (Values in Cr)
    Net Income 204.81
    Cash from Operations 216.52
    Cash from Investing -131.13
    Cash from Financing -30.53
    Net change in Cash 0.02
    Free Cash Flow 347.21
    Particulars MAR 2022 (Values in Cr)
    Net Income 255.49
    Cash from Operations 119.98
    Cash from Investing -125.35
    Cash from Financing 84.11
    Net change in Cash -1.35
    Free Cash Flow 246.85
    Particulars MAR 2021 (Values in Cr)
    Net Income 337.71
    Cash from Operations 241.95
    Cash from Investing -69.03
    Cash from Financing -85.27
    Net change in Cash -0.13
    Free Cash Flow 322.72
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 12.85 1.49 237.26 23.12 38.85
    BLISS GVS PHARMA LTD. 482.50 38.79 4.28 5117.21 118.35 552.90
    CIPLA LTD 1418.40 30.10 3.32 114584.78 1165.55 1672.20
    FERMENTA BIOTECH LTD. 431.50 19.03 3.12 1269.95 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 30.96 21.65 3.98 237.26 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 537.90 24.11 4.20 1555.10 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8025.95 104.82 22.98 20064.88 7630.00 9850.00
    BLISS GVS PHARMA LTD. 482.50 52.16 4.42 5117.21 118.35 552.90

    AARTI DRUGS LTD. shareholding pattern

    Holding
    33.17%
    55.02%
    1.57%
    10.21%
    2.47%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    AARTI DRUGS LTD. Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    422.30 0.57 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 414.00
    • 26 Days 391.30
    • 10 Days 404.90
    • 50 Days 384.20
    • 12 Days 402.10
    • 100 Days 383.50
    • 20 Days 394.70
    • 200 Days 398.40
    424.63 PIVOT
    First Support 414.02 First Resistance 430.52 Second Support 408.13 Second Resistance 441.13 Third Support 397.52 Third Resistance 447.02
    RSI 74.61 ADX 57.49 MACD 10.78 Williams % R -19.55 Commodity Channel Index (CCI) 152.98
    Date 2026-07-17 Week 144247.00 Same Day 104731.00 Month 108701.00
    1 Year 0.91 3 Year 0.75
    Over 1 Month
    14.84% down
    Over 1 Year
    -18.44% down
    Over 3 Months
    13.15% down
    Over 3 Years
    -5.79% down
    Over 6 Months
    12.16% down
    Over 5 Years
    -10.13% down

    AARTI DRUGS LTD. Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    09 Feb 2026 2.0 Interim 09 Feb 2026 Equity shares
    04 Feb 2025 1.0 Interim 04 Feb 2025 Equity shares
    06 Feb 2024 1.0 Interim 06 Feb 2024 Equity shares
    08 Feb 2023 1.0 Interim 08 Feb 2023 Equity shares
    09 Feb 2022 1.0 Interim 10 Feb 2022 Equity shares
    03 Nov 2020 2.5 Interim 04 Nov 2020 Equity shares
    17 Feb 2020 2.0 Interim 18 Feb 2020 Equity shares
    26 Jul 2019 1.0 Final 30 Jul 2019 Equity shares
    01 Aug 2018 1.0 Final 03 Aug 2018 Equity shares
    09 Aug 2017 1.0 Final 11 Aug 2017 Equity shares
    22 Mar 2016 3.0 Interim 3 24 Mar 2016 Equity shares
    12 Feb 2016 1.5 Interim 2 15 Feb 2016 Equity shares
    10 Nov 2015 2.25 Interim 14 Nov 2015 Equity shares
    05 Aug 2015 3.0 Final 07 Aug 2015 Equity shares
    04 Feb 2015 5.0 Interim 2 05 Feb 2015 Equity shares
    19 Nov 2014 5.0 Interim 1 20 Nov 2014 Equity shares
    02 Jul 2014 5.5 Final 04 Jul 2014 Equity shares
    05 Feb 2014 4.5 Interim 2 06 Feb 2014 Equity shares
    19 Nov 2013 3.0 Interim 14 Nov 2013 Equity shares
    24 Jul 2013 4.0 Final 26 Jul 2013 Equity shares
    11 Feb 2013 3.0 Interim 2 12 Feb 2013 Equity shares
    05 Nov 2012 3.0 Interim 06 Nov 2012 Equity shares
    17 Aug 2012 3.0 Final 22 Aug 2012 Equity shares
    06 Feb 2012 2.0 Interim 07 Feb 2012 Equity shares
    14 Jul 2011 2.5 Final 16 Jul 2011 Equity shares
    07 Feb 2011 2.5 Interim 08 Feb 2011 Equity shares
    18 Aug 2010 5.0 Final 21 Aug 2010 Equity shares
    23 Jul 2009 3.0 Final 25 Jul 2009 Equity shares
    13 Aug 2008 1.8 Final 16 Aug 2008 Equity shares
    20 Mar 2007 1.2 Final 21 Mar 2007 Equity shares
    27 Jul 2005 0.0 Final 29 Jul 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    01 Oct 2020 30 Sep 2020 3:1
    25 Mar 2015 24 Mar 2015 1:1
    11 Jun 1996 13 May 1996 1:2
    Dividend date Dividend amount Dividend type Record date Instrument type
    09 Feb 2026 2.0 Interim 09 Feb 2026 Equity shares
    04 Feb 2025 1.0 Interim 04 Feb 2025 Equity shares
    06 Feb 2024 1.0 Interim 06 Feb 2024 Equity shares
    08 Feb 2023 1.0 Interim 08 Feb 2023 Equity shares
    09 Feb 2022 1.0 Interim 10 Feb 2022 Equity shares
    03 Nov 2020 2.5 Interim 04 Nov 2020 Equity shares
    17 Feb 2020 2.0 Interim 18 Feb 2020 Equity shares
    26 Jul 2019 1.0 Final 30 Jul 2019 Equity shares
    01 Aug 2018 1.0 Final 03 Aug 2018 Equity shares
    09 Aug 2017 1.0 Final 11 Aug 2017 Equity shares
    22 Mar 2016 3.0 Interim 3 24 Mar 2016 Equity shares
    12 Feb 2016 1.5 Interim 2 15 Feb 2016 Equity shares
    10 Nov 2015 2.25 Interim 14 Nov 2015 Equity shares
    05 Aug 2015 3.0 Final 07 Aug 2015 Equity shares
    04 Feb 2015 5.0 Interim 2 05 Feb 2015 Equity shares
    19 Nov 2014 5.0 Interim 1 20 Nov 2014 Equity shares
    02 Jul 2014 5.5 Final 04 Jul 2014 Equity shares
    05 Feb 2014 4.5 Interim 2 06 Feb 2014 Equity shares
    19 Nov 2013 3.0 Interim 14 Nov 2013 Equity shares
    24 Jul 2013 4.0 Final 26 Jul 2013 Equity shares
    11 Feb 2013 3.0 Interim 2 12 Feb 2013 Equity shares
    05 Nov 2012 3.0 Interim 06 Nov 2012 Equity shares
    17 Aug 2012 3.0 Final 22 Aug 2012 Equity shares
    06 Feb 2012 2.0 Interim 07 Feb 2012 Equity shares
    14 Jul 2011 2.5 Final 16 Jul 2011 Equity shares
    07 Feb 2011 2.5 Interim 08 Feb 2011 Equity shares
    18 Aug 2010 5.0 Final 21 Aug 2010 Equity shares
    23 Jul 2009 3.0 Final 25 Jul 2009 Equity shares
    13 Aug 2008 1.8 Final 16 Aug 2008 Equity shares
    20 Mar 2007 1.2 Final 21 Mar 2007 Equity shares
    27 Jul 2005 0.0 Final 29 Jul 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    01 Oct 2020 30 Sep 2020 3:1
    25 Mar 2015 24 Mar 2015 1:1
    11 Jun 1996 13 May 1996 1:2

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Aarti Drugs Ltd?

    Answer Field

    Aarti Drugs Ltd share price is for NSE ₹ 422.30 & for BSE ₹ 422.95 as on Jul 17 2026 03:30 PM.

    What is the Market Cap of Aarti Drugs Ltd Share?

    Answer Field

    The market cap of Aarti Drugs Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 17 2026 03:30 PM.

    What is the 52 Week High and Low of Aarti Drugs Ltd?

    Answer Field

    The 52 Week High and Low of Aarti Drugs Ltd for NSE is ₹ 564.05 and ₹ 318.95 and for BSE is ₹ 574.95 and ₹ 318.60.

    What is 1 year return for Aarti Drugs Ltd?

    Answer Field

    The 1 year returns on the stock has been -18.44%.

    What is the P/E Ratio of Aarti Drugs Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM the price-to-earnings (PE) ratio for Aarti Drugs Ltd share is 22.81.

    What is the PB ratio of Aarti Drugs Ltd Share?

    Answer Field

    As on Jul 17 2026 03:30 PM, the price-to-book (PB) ratio for Aarti Drugs Ltd share is 153.91.

    How to Buy Aarti Drugs Ltd Share?

    Answer Field

    You can trade in Aarti Drugs Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Aarti Drugs Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Aarti Drugs Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Aarti Drugs Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |